These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7209729)

  • 21. The control of genetic disease by carrier screening and antenatal diagnosis: social, ethical, and medicolegal issues.
    Kaback MM
    Birth Defects Orig Artic Ser; 1982; 18(7):243-54. PubMed ID: 7159734
    [No Abstract]   [Full Text] [Related]  

  • 22. The Tay-Sachs disease prevention program in Australia: Sydney pilot study.
    Burnett L; Proos AL; Chesher D; Howell VM; Longo L; Tedeschi V; Yang VA; Siafakas N; Turner G
    Med J Aust; 1995 Sep; 163(6):298-300. PubMed ID: 7565235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
    Zlotogora J; Leventhal A
    Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-based genetic education: sources of information in a Tay Sachs disease screening program.
    Clark M; Palmer R; Kontras S
    Ohio State Med J; 1982 Mar; 78(3):218-20. PubMed ID: 7078924
    [No Abstract]   [Full Text] [Related]  

  • 25. A genetic profile of the South African Ashkenazi Jewish population.
    Lane AB; Dunn DS; Jenkins T
    S Afr Med J; 1985 Dec; 68(13):935-9. PubMed ID: 4081927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal.
    Zeesman S; Clow CL; Cartier L; Scriver CR
    Am J Med Genet; 1984 Aug; 18(4):769-78. PubMed ID: 6486173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons from the American Tay-Sachs Programme.
    Steele MW
    Lancet; 1980 Oct; 2(8200):914. PubMed ID: 6107561
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of the physician in screening for carriers of Tay-Sachs disease.
    Lowden JA
    Can Med Assoc J; 1978 Sep; 119(6):575-8. PubMed ID: 709448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carrier parents of Tay Sachs disease and beta-thalassemia.
    Shah B; Bhavsar R
    Indian Pediatr; 2005 May; 42(5):498-9. PubMed ID: 15923705
    [No Abstract]   [Full Text] [Related]  

  • 30. Pedigree discriminant analysis of two French Canadian Tay-Sachs families.
    Keats BJ; Elston RC; Andermann E
    Genet Epidemiol; 1987; 4(2):77-85. PubMed ID: 2953646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
    Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
    Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tay-Sachs disease carrier screening: follow-up of a case-finding approach.
    Clarke JT; Skomorowski MA; Zuker S
    Am J Med Genet; 1989 Dec; 34(4):601-5. PubMed ID: 2624277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal testing for Tay-Sachs disease in the light of Jewish views regarding abortion.
    Baskin J
    Issues Health Care Women; 1983; 4(1):41-56. PubMed ID: 6553058
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening and prevention in Tay-Sachs disease: origins, update, and impact.
    Kaback MM
    Adv Genet; 2001; 44():253-65. PubMed ID: 11596988
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for the Tay-Sachs carrier: a compromise program.
    Potter JL; Robinson HB
    Clin Chem; 1981 Apr; 27(4):523-5. PubMed ID: 7471417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Not preventing--yet, just avoiding Tay-Sachs disease.
    Scriver CR
    Adv Genet; 2001; 44():267-74. PubMed ID: 11596989
    [No Abstract]   [Full Text] [Related]  

  • 37. Tay-Sachs disease and HEXA mutations among Moroccan Jews.
    Kaufman M; Grinshpun-Cohen J; Karpati M; Peleg L; Goldman B; Akstein E; Adam A; Navon R
    Hum Mutat; 1997; 10(4):295-300. PubMed ID: 9338583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tay-Sachs disease: a pilot screening program for the detection of the heterozygote in the Charleston Jewish community.
    Rogers JF; Hogan EL; Jorgenson RJ
    South Med J; 1976 Nov; 69(11):1453-5. PubMed ID: 1019641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tay-Sachs disease: to screen or not to screen.
    Rosner F
    Tradition; 1976; 15(4):101-12. PubMed ID: 11660898
    [No Abstract]   [Full Text] [Related]  

  • 40. Lower frequency of Gaucher disease carriers among Tay-Sachs disease carriers.
    Peleg L; Frisch A; Goldman B; Karpaty M; Narinsky R; Bronstein S; Frydman M
    Eur J Hum Genet; 1998; 6(2):185-6. PubMed ID: 9781065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.